1 completed, 1 withdrawn. 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Aaron Boster: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy Ziconotide, placebo - Painful Myelopathy, Painful Neuropathy | Phase 4 | Withdrawn | Aaron Boster | 2014-01-01 | 2018-09-18 | |
| Combination Therapy Using Cellcept and Rebif in RRMS mycophenolate mofetil (Cellcept), human interferon beta 1a (Rebif) - Multiple Sclerosis | Early Phase 1 | Completed | Aaron Boster | 31 | 2006-08-01 | 2012-11-15 |
Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Neuropathy, Painful (1)
Interferon beta-1a (1) · Mycophenolic Acid (1) · ziconotide (1)
United States (2)